Latest studies
- Not yet recruiting
Phase 3a and 3b update of the gastric cancer module, EORTC QLQ-STO22
Researchers are updating a widely used questionnaire that measures how stomach cancer and modern treatments affect daily life and well-being. If you have stomach cancer, you can help by completing the draft survey and sharing your feedback during a single, one-off chat lasting up to an hour.
Gastric adenocarcinomaMongolia - Recruiting
Exploring the hidden burden of living with Glanzmann thrombasthenia
This study wants to hear from people living with Glanzmann thrombasthenia (GT) and their caregivers. We want to understand the daily challenges and feelings of those affected. Your stories can help improve support and understanding for everyone with GT.
Glanzmann thrombastheniaMongolia - Active not recruitingPHASE3
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
This study is testing a new medicine, Rifaximin SSD, to see if it can delay serious liver problems called Hepatic Encephalopathy in people with liver scarring (cirrhosis). It's comparing the new medicine to a dummy pill to see which works better and if it's safe.
Hepatic EncephalopathyMongolia